← Leaderboards
Daewoo Lee
Ohio University Athens
$1,191,954
Attributed
$1,191,954
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $453K · FY2005–23$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$1,191,954 · 3
By mechanism
R21$738,954 · 2
R15$453,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposUptakeAffectPathogenicityPrion-LikeTransgenic OrganismsInsightMediatingNeurodegenerative DisordersOptogeneticsPhosphorylationC-TerminalProteinsTherapeutic TargetMolecularDisease ProgressionDrosophila GenusInterestMutantNerve DegenerationCellsNeuronsPathologyDementia With Lewy Bodies
Grant awards (4)
Activity-dependent release of human alpha-synuclein$403,010
R21 · FY2023 · NS · contact PI
Phosphorylation-dependent human tau release$453,000
R15 · FY2020 · AG · contact PI
Role of dopamine in alpha-Syn-mediated neurodegeneration$165,975
R21 · FY2006 · NS · contact PI
Role of dopamine in alpha-Syn-mediated neurodegeneration$169,969
R21 · FY2005 · NS